Wall Street analysts expect Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) to announce $787.09 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Calumet Specialty Products Partners, L.P’s earnings, with estimates ranging from $737.18 million to $837.00 million. Calumet Specialty Products Partners, L.P reported sales of $1.10 billion during the same quarter last year, which would suggest a negative year over year growth rate of 28.4%. The firm is expected to issue its next quarterly earnings report on Thursday, December 27th.

On average, analysts expect that Calumet Specialty Products Partners, L.P will report full year sales of $3.17 billion for the current fiscal year, with estimates ranging from $3.10 billion to $3.24 billion. For the next fiscal year, analysts forecast that the firm will post sales of $2.97 billion per share, with estimates ranging from $2.79 billion to $3.15 billion. Zacks Investment Research’s sales averages are an average based on a survey of research firms that follow Calumet Specialty Products Partners, L.P.

Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) last posted its quarterly earnings data on Thursday, August 9th. The oil and gas company reported $0.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.08 by $0.01. Calumet Specialty Products Partners, L.P had a negative net margin of 3.94% and a negative return on equity of 45.02%. The company had revenue of $945.50 million during the quarter, compared to the consensus estimate of $829.99 million.

Several research firms have weighed in on CLMT. BidaskClub raised shares of Calumet Specialty Products Partners, L.P from a “hold” rating to a “buy” rating in a research note on Tuesday, June 5th. Zacks Investment Research downgraded shares of Calumet Specialty Products Partners, L.P from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 30th. Finally, ValuEngine downgraded shares of Calumet Specialty Products Partners, L.P from a “hold” rating to a “sell” rating in a research note on Monday, August 20th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $7.92.

Calumet Specialty Products Partners, L.P stock opened at $6.90 on Monday. The company has a quick ratio of 0.75, a current ratio of 1.45 and a debt-to-equity ratio of 29.68. The firm has a market capitalization of $531.98 million, a price-to-earnings ratio of -12.32 and a beta of 1.29. Calumet Specialty Products Partners, L.P has a twelve month low of $6.10 and a twelve month high of $9.95.

In other news, CFO David West Griffin acquired 11,000 shares of the stock in a transaction dated Wednesday, September 5th. The stock was purchased at an average cost of $6.57 per share, with a total value of $72,270.00. Following the completion of the purchase, the chief financial officer now owns 65,405 shares in the company, valued at approximately $429,710.85. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Over the last ninety days, insiders have bought 30,349 shares of company stock valued at $199,127. Insiders own 4.75% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in CLMT. JPMorgan Chase & Co. increased its position in shares of Calumet Specialty Products Partners, L.P by 17.2% during the first quarter. JPMorgan Chase & Co. now owns 82,000 shares of the oil and gas company’s stock valued at $578,000 after buying an additional 12,037 shares during the period. Knott David M purchased a new position in shares of Calumet Specialty Products Partners, L.P during the first quarter valued at about $6,666,000. UBS Group AG grew its holdings in Calumet Specialty Products Partners, L.P by 34.8% in the first quarter. UBS Group AG now owns 211,856 shares of the oil and gas company’s stock worth $1,494,000 after purchasing an additional 54,659 shares during the period. Eqis Capital Management Inc. purchased a new stake in Calumet Specialty Products Partners, L.P in the second quarter worth about $118,000. Finally, Windsor Group LTD grew its holdings in Calumet Specialty Products Partners, L.P by 2.8% in the second quarter. Windsor Group LTD now owns 450,221 shares of the oil and gas company’s stock worth $3,354,000 after purchasing an additional 12,121 shares during the period. Institutional investors own 13.96% of the company’s stock.

Calumet Specialty Products Partners, L.P Company Profile

Calumet Specialty Products Partners, L.P. produces and sells specialty hydrocarbon products in North America and internationally. It operates in two segments, Specialty Products and Fuel Products. The Specialty Products segment offers various lubricating oils, white mineral oils, solvents, petrolatums, waxes, synthetic lubricants, and other products which are used primarily as raw material components for basic automotive, industrial, and consumer goods.

Recommended Story: How to Track your Portfolio in Google Finance

Get a free copy of the Zacks research report on Calumet Specialty Products Partners, L.P (CLMT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Calumet Specialty Products Partners L.P Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners L.P and related companies with MarketBeat.com's FREE daily email newsletter.